Delivery Order SPE2DB24D2003-SPE2DB24FXFJ4
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, ZEPBOUND 15 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order with a Firm Fixed Price valued at $1,053.76. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with an ultimate completion date of May 21, 2024. The contract is under the Medical Supply Chain program of the Defense Logistics Agency (DLA), which serves the U.S. Department of Defense. This award does not have a set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,698.10 for the supply of the pharmaceutical product "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML". The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is the primary logistics provider for the U.S. Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order contract valued at $1,053.76. The contract is for the supply of a pharmaceutical product, "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML," to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the medication ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, to the Defense Logistics Agency (DLA). The $1,053.76 firm fixed price Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,919.60 Delivery Order placed by the Defense Logistics Agency (DLA). The award is for the provision of a pharmaceutical product, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 2, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,069.45 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA), a defense agency. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $18,016.03 firm fixed-price delivery order is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,915.12 for the supply of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is from the Defense Logistics Agency (DLA), a defense agency, and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...